vTv Therapeutics, Inc. (VTVT)
37.81
+0.06
(+0.16%)
USD |
NASDAQ |
Apr 21, 10:16
vTv Therapeutics EPS Diluted (Quarterly) : -0.5752 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 1.150 |
| Tactile Systems Technology, Inc. | 0.4615 |
| Design Therapeutics, Inc. | -0.2724 |
| Immuneering Corp. | -0.1793 |
| X4 Pharmaceuticals, Inc. | -0.2164 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.138M |
| Total Expenses (Quarterly) | 7.138M |
| Enterprise Value | 59.75M |
| Earnings Yield | -8.85% |
| Normalized Earnings Yield | -8.849 |